Company Information

CIN
Status
Date of Incorporation
13 March 1991
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
21 August 2023
Paid Up Capital
90,603,220
Authorised Capital
150,000,000

Directors

Venkatanaga Kali Vara Prasada Raju Vetukuri
Venkatanaga Kali Vara Prasada Raju Vetukuri
Director/Designated Partner
about 2 years ago
Pankaj Bhuneshwar Patwari
Pankaj Bhuneshwar Patwari
Director/Designated Partner
about 2 years ago
Shweta Jalan
Shweta Jalan
Director/Designated Partner
about 2 years ago
Sunil Govind Uttarwar
Sunil Govind Uttarwar
Director/Designated Partner
over 2 years ago
Jayant Bhalchandra Manmadkar
Jayant Bhalchandra Manmadkar
Director/Designated Partner
over 2 years ago
Nihar Ajay Parikh
Nihar Ajay Parikh
Director/Designated Partner
almost 3 years ago
Anil Kumar Chanana
Anil Kumar Chanana
Director/Designated Partner
almost 4 years ago
Abhijit Mangalmoy Mukherjee
Abhijit Mangalmoy Mukherjee
Director/Designated Partner
over 4 years ago
Bhaskar Vemban Iyer
Bhaskar Vemban Iyer
Director/Designated Partner
over 4 years ago
Jayesh Tulsidas Merchant
Jayesh Tulsidas Merchant
Director
over 4 years ago
Ajay Krishnakant Parikh
Ajay Krishnakant Parikh
Director/Designated Partner
about 6 years ago
Anuja Saumik Doshi
Anuja Saumik Doshi
Wholetime Director
over 7 years ago
Sudarshan Kailash Chandra Jain
Sudarshan Kailash Chandra Jain
Director
over 7 years ago

Past Directors

Nirav Vinod Mehta
Nirav Vinod Mehta
Alternate Director
almost 9 years ago
Ling Wei Ong
Ling Wei Ong
Nominee Director
almost 9 years ago
Hargovind Rathore
Hargovind Rathore
Additional Director
over 9 years ago
Piyush Maganlal Nathwani
Piyush Maganlal Nathwani
Whole Time Director
over 10 years ago
Dinesh Bhagwanji Rachh
Dinesh Bhagwanji Rachh
Company Secretary
about 11 years ago
Upendra Jayantilal Sheth
Upendra Jayantilal Sheth
Director Appointed In Casual Vacancy
almost 12 years ago
Minoti Ajay Parikh
Minoti Ajay Parikh
Director
almost 17 years ago
Manish Rasiklal Bavishi
Manish Rasiklal Bavishi
Director
almost 17 years ago
Padmanabh Pundrikray Vora
Padmanabh Pundrikray Vora
Director
almost 19 years ago
Krishnaswami Natarajan
Krishnaswami Natarajan
Director
about 20 years ago
Girish Gopaldas Parikh
Girish Gopaldas Parikh
Director
almost 34 years ago

Patents

''An Improved Process For The Preparation Of 3 Aryloxy 3 Phenylpropyl Amine And Salt Thereof''

The present invention relates to an industrially feasible and economically viable process for the preparation of 3-aryloxy-3-phenylpropylamine and salt of formula I thereof.

"An Improved Process For The Preparation Of 1 (2,3 Dichlorophenyl) Piperazine And Its Salt Thereof"

The present invention relates to an industrially feasible and economically viable process for the preparation of l-(2,3-dichloro-phenyl)piperazine and its salt of formula I thereof.

An Improved Process For The Preparation Of Lurasidone Base And Its Salt

The present invention relates to an industrially feasible process for preparation of substantially pure Lurasidone base of formula la and its conversion to pharmaceutically acceptable salts such as hydrochloride salt and the like in significantly high yields and purity.

"An Improved Process For The Preparation Of Fluvoxamine Maleate"

The present invention relates to an industrially feasible and economically viable process for the preparation of fluvoxamine maleate of formula I.

"A Process For The Preparation Of Pure Aripiprazole Type I Crystal"

The present invention relates to an improved and industrially applicable process for the preparation of aripiprazole and its crystal form of formula I thereof.

"A Process For The Preparation Of Methylphenidate Hydrochloride And Its Intermediates Thereof"

The present invention relates to an industrially feasible and economically viable process for the preparation of methylphenidate hydrochloride of formula 1 and its intermediates thereof.

"An Improved Process For The Preparation Of Memantine Hydrochloride"

The present invention relates to an improved process for the preparation of Memantine hydrochloride of formula (1). Memantine hydrochloride is used in the treatment of Alzheimer"s and Parkinson"s disease.

"An Improved Process For The Preparation Of Dexmethylphenidate Hydrochloride"

The present invention relates to an improved process for the preparation of Dexmethylphenidate hydrochloride of formula (A). More particularly, the present invention relates to an improved process for the preparation of Dexmethylphenidate hydrochloride of formula (A) and its intermediate d-threo ritalinic acid hydro...

" A Process For Preparing Nebivolol Hydrochloride"

The present invention relates to an industrially feasible and economically viable process foT the preparation of nebivolol hydrochloride of formula I thereof.

"A Process For The Preparation Of D Threo Ritalinic Acid Salts Via Novel Salts Of Intermediate Thereof"

The present invention relates to a process for the preparation of d-threo-ritalinic acid salt thereof. More particularly, the present invention relates a process for the preparation of d-threo-ritalinic acid salt via novel organic salts of intermediate thereof.

"An Improved Process For The Preparation Of Levomepromazine Maleate"

The  present  invention  relates  to  an  industrially  viable  and  environmentally advantageous process for the preparation of levomepromazine maleate.

"A Novel Process To Prepare Intermediates Of Hiv Protease Inhibitors Thereof"

ABSTRACT The present invention relates to an industrially feasible and economically viable process for the preparation of (lS,2R)-3-[[4-aminophenyl)-suifonyi](2-methylpropy!)amino]-2-hydroxy-l-(phenyl-methyl)propyl] amine of formula I and its salt thereof and optionally converting it to HIV-protease inhibitors like...

"A Process For The Preparation Of Flupirtine Maleate"

The present invention relates to an industrially feasible and economically viable process for the preparation of flupirtine maleate of formula I thereof.

Novel Process For Preparation Of Crystalline Form Of Pirfenidone

ABSTRACT “Novel process for preparation of crystalline form of Pirfenidone” The present invention provides Novel process for preparation of a process for purification of Pirfenidone involving treating Pirfenidone with a quaternary ammonium salt. The present invention further provides a novel process for the pr...

"A Process For The Kinetic Resolution Of Racemic Alcohols As Applied To Preparation Of Eslicarbazepine Acetate"

The present invention relates to an industrially applicable process for kinetic resolution of racemic mixture of alcohol such as a mixture of (R) - and (S) - hydroxyl compounds. More particularly, the present invention relates to an industrially applicable process for separation of Eslicarbazepine from a racemic mix...

An Improved Process For The Preparation Of Ticagrelor

An Improved process for the preparation of Ticagrelor The present invention provides an improved process for the preparation of Ticagrelor. The improved process comprises of preparing compound of formula III by reacting compound of formula I and formula II or a salt thereof in presence of a base and a non-polar org...

“An Improved Process For Preparation Of Maraviroc”

The present invention provides improved isolation process for preparation of Maraviroc intermediate with high purity. The present invention further provides an improved process for preparation of Maraviroc compound of formula I with high purity.

An Improved Process For Preparation Of Bempedoic Acid

The present invention provides an improved process for the preparation of Bempedoic acid compound of formula I and its intermediates having high purity and high yield. Further present invention provides process for purification of Bempedoic acid compound of formula I. Dated this 8th day of November, 2021 ...

An Improved Process For The Synthesis Of Favipiravir

The present invention relates to a process for the preparation of Anti influenza drug Favipiravir. The process being developed is one-pot synthesis which avoids isolation of intermediate compounds that are formed during the synthesis of Favipiravir. The present invention also provides a novel purification process wh...

An Improved Process For The Preparation Of Miglustat

The present invention provides an alternative approach for the preparation of Miglustat compound of formula IV and its intermediates having high purity. In particular, the present invention provides a process for the preparation of Miglustat through the tetra-O-protected 1-D-gluco-deoxynojirimycin or the tetra-O-pro...

An Improved Process For The Preparation Of Enantiomerically Pure (4 R) 1 Methyl 4 (1 Methylethenyl) 2 Cyclohexen 1 Ol

The present invention provides a process for the preparation of enantiomerically pure (4R)-1-Methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol compound of formula II, an intermediate in the synthesis of Cannabidiol. Further, the present invention relates to a process for the preparation of enantiomerically pure (4R)-2-(d...

Registered Trademarks

Zcl Zcl Chemicals

[Class : 5] Pharmaceutical Products, Pharmaceutical Preparations&Nbsp;Included In Class 05

Zcl Zcl Chemicals

[Class : 5] Pharmaceutical Products, Pharmaceutical Preparations Included In Class O5

Charges

113 Crore
27 July 2015
State Bank Of India
10 Crore
23 November 2012
Citi Bank N.a.
78 Crore
15 July 2011
State Bank Of India
10 Crore
23 December 2010
State Bank Of India
24 Crore
23 November 2012
Citibank N. A.
5 Crore
09 August 2010
Export-import Bank Of India
7 Crore
03 October 2009
Export-import Bank Of India
15 Crore
10 November 1993
Union Bank Of India
5 Lak
26 March 2003
Corporation Bank
46 Crore
22 June 2002
Bank Of Baroda
40 Lak
21 November 2001
Bank Of Baroda
8 Crore
15 September 1997
Bank Of Baroda
25 Lak
22 September 1999
Bank Of Baroda
4 Crore
19 February 1992
Bank Of Baroda
13 Lak
15 January 2002
Bank Of Baroda
1 Crore
15 September 1994
Bank Of Baroda
25 Lak
22 April 1998
Gujrat Industrial Investment Corporation
60 Lak
06 March 1992
Gujrat Industrial Investment Corporation
80 Lak
10 February 2021
Hdfc Bank Limited
15 Crore
13 March 2023
Axis Bank Limited
0
10 February 2021
Hdfc Bank Limited
0
27 July 2015
State Bank Of India
0
15 July 2011
State Bank Of India
0
06 March 1992
Gujrat Industrial Investment Corporation
0
15 January 2002
Bank Of Baroda
0
22 September 1999
Bank Of Baroda
0
10 November 1993
Union Bank Of India
0
15 September 1994
Bank Of Baroda
0
19 February 1992
Bank Of Baroda
0
23 November 2012
Citi Bank N.a.
0
26 March 2003
Corporation Bank
0
15 September 1997
Bank Of Baroda
0
22 June 2002
Bank Of Baroda
0
21 November 2001
Bank Of Baroda
0
23 December 2010
State Bank Of India
0
23 November 2012
Citibank N. A.
0
22 April 1998
Gujrat Industrial Investment Corporation
0
09 August 2010
Export-import Bank Of India
0
03 October 2009
Export-import Bank Of India
0
13 March 2023
Axis Bank Limited
0
10 February 2021
Hdfc Bank Limited
0
27 July 2015
State Bank Of India
0
15 July 2011
State Bank Of India
0
06 March 1992
Gujrat Industrial Investment Corporation
0
15 January 2002
Bank Of Baroda
0
22 September 1999
Bank Of Baroda
0
10 November 1993
Union Bank Of India
0
15 September 1994
Bank Of Baroda
0
19 February 1992
Bank Of Baroda
0
23 November 2012
Citi Bank N.a.
0
26 March 2003
Corporation Bank
0
15 September 1997
Bank Of Baroda
0
22 June 2002
Bank Of Baroda
0
21 November 2001
Bank Of Baroda
0
23 December 2010
State Bank Of India
0
23 November 2012
Citibank N. A.
0
22 April 1998
Gujrat Industrial Investment Corporation
0
09 August 2010
Export-import Bank Of India
0
03 October 2009
Export-import Bank Of India
0

Documents

Form INC-22-22122020_signed
Copy of board resolution authorizing giving of notice-18122020
Copies of the utility bills as mentioned above (not older than two months)-18122020
Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-18122020
Optional Attachment-(1)-18122020
Optional Attachment-(2)-18122020
Copy of MGT-8-17112020
Optional Attachment-(1)-17112020
-17112020
Form MGT-7-17112020_signed
Optional Attachment-(2)-30102020
Optional Attachment-(1)-30102020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-30102020
Form AOC-4(XBRL)-30102020_signed
Form MSME FORM I-29102020_signed
Form DPT-3-20102020-signed
Form DIR-12-05102020_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-29092020
Declaration by first director-29092020
Form PAS-6-15092020_signed
Optional Attachment-(1)-15092020
Form PAS-6-11092020_signed
Optional Attachment-(1)-11092020
Form MSME FORM I-12062020_signed
Form DPT-3-14052020-signed
Form MSME FORM I-30102019_signed
Form MGT-7-23102019_signed
List of share holders, debenture holders;-22102019
Copy of MGT-8-22102019
Optional Attachment-(2)-20092019